Skip to main content

Advertisement

SpringerLink
Log in

Reducing Morbidity of Pelvic and Retroperitoneal Lymphadenectomy

  • Surgical Techniques (J Cadeddu and A Stenzl, Section Editors)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Lymphadenectomy is utilized in both pelvic and retroperitoneal oncological surgery as a means to eradicate locoregional disease, improve staging accuracy and guide adjuvant therapy. However, pelvic and retroperitoneal lymphadenectomy have the potential for morbidity including lymphatic injury, vascular injury, thromboembolic events and neurologic injury. Across the spectrum of urologic malignancies, the evidence supporting both the necessity and the extent of lymphadenectomy varies considerably. Awareness of the potential for injury and ways to avoid and manage the most common complications is necessary to decrease the morbidity associated with these procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently have been highlighted as: • Of importance

  1. Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med. 1999;341(24):1781–8.

    Article  PubMed  CAS  Google Scholar 

  2. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol. 2002;167(3):1295–8.

    Article  PubMed  Google Scholar 

  3. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19(3):666–75.

    PubMed  CAS  Google Scholar 

  4. Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol. 2008;179(3):873–8. discussion 878.

    Article  PubMed  Google Scholar 

  5. • Blom JH, van Poppel H, Marechal JM, Jacqmin D, Schroder FH, de Prijck L, et al. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol. 2009;55(1):28–34. This randomized trial represents the only level 1 evidence in the urological literature on the benefit of LND, and shows no survival benefit of LND at the time of radical nephrectomy.

    Article  PubMed  Google Scholar 

  6. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. J Urol. 1993;149(2):237–43.

    PubMed  CAS  Google Scholar 

  7. Heidenreich A, Thuer D, Polyakov S. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis. Eur Urol. 2008;53(2):260–72.

    Article  PubMed  Google Scholar 

  8. Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol. 2004;172(5 Pt 1):1840–4.

    Article  PubMed  Google Scholar 

  9. Musch M, Klevecka V, Roggenbuck U, Kroepfl D. Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006. J Urol. 2008;179(3):923–8. discussion 928–9.

    Article  PubMed  Google Scholar 

  10. Swanson GP, Thompson IM, Basler J. Current status of lymph node-positive prostate cancer: incidence and predictors of outcome. Cancer. 2006;107(3):439–50.

    Article  PubMed  Google Scholar 

  11. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 2001;58(6):843–8.

    Article  PubMed  CAS  Google Scholar 

  12. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997;277(18):1445–51.

    Article  PubMed  CAS  Google Scholar 

  13. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969–74.

    Article  PubMed  Google Scholar 

  14. Kawakami J, Meng MV, Sadetsky N, Latini DM, Duchane J, Carroll PR, et al. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE. J Urol. 2006;176(4 Pt 1):1382–6.

    Article  PubMed  Google Scholar 

  15. NCCN Clinical Practice Guidelines in Oncology, Prostate Cancer, Version 2.2013. Accessed 3/11/2013.

  16. Tsukamoto T, Kitamura H, Takahashi A, Masumori N. Treatment of invasive bladder cancer: lessons from the past and perspective for the future. Jpn J Clin Oncol. 2004;34(6):295–306.

    Article  PubMed  Google Scholar 

  17. Soloway MS, Lopez AE, Patel J, Lu Y. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer. 1994;73(7):1926–31.

    Article  PubMed  CAS  Google Scholar 

  18. Leissner J, Ghoneim MA, Abol-Enein H, Thuroff JW, Franzaring L, Fisch M, et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol. 2004;171(1):139–44.

    Article  PubMed  CAS  Google Scholar 

  19. Solberg A, Angelsen A, Bergan U, Haugen OA, Viset T, Klepp O. Frequency of lymphoceles after open and laparoscopic pelvic lymph node dissection in patients with prostate cancer. Scand J Urol Nephrol. 2003;37(3):218–21.

    Article  PubMed  Google Scholar 

  20. Keegan KA, Cookson MS. Complications of pelvic lymph node dissection for prostate cancer. Curr Urol Rep. 2011;12(3):203–8.

    Article  PubMed  CAS  Google Scholar 

  21. Gotto GT, Yunis LH, Guillonneau B, Touijer K, Eastham JA, Scardino PT, et al. Predictors of symptomatic lymphocele after radical prostatectomy and bilateral pelvic lymph node dissection. Int J Urol. 2011.

  22. Pepper RJ, Pati J, Kaisary AV. The incidence and treatment of lymphoceles after radical retropubic prostatectomy. BJU Int. 2005;95(6):772–5.

    Article  PubMed  Google Scholar 

  23. Alago Jr W, Deodhar A, Michell H, Sofocleous CT, Covey AM, Solomon SB, et al. Management of postoperative lymphoceles after lymphadenectomy: percutaneous catheter drainage with and without povidone-iodine sclerotherapy. Cardiovasc Intervent Radiol. 2013;36(2):466–71.

    Article  PubMed  Google Scholar 

  24. Treiyer A, Haben B, Stark E, Breitling P, Steffens J. Uni- vs. multiloculated pelvic lymphoceles: differences in the treatment of symptomatic pelvic lymphoceles after open radical retropubic prostatectomy. Int Braz J Urol. 2009;35(2):164–9. discussion 170.

    Article  PubMed  Google Scholar 

  25. Clark T, Parekh DJ, Cookson MS, Chang SS, Smith Jr ER, Wells N, et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol. 2003;169(1):145–7. discussion 147–8.

    Article  PubMed  Google Scholar 

  26. Briganti A, Chun FK, Salonia A, Suardi N, Gallina A, Da Pozzo LF, et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol. 2006;50(5):1006–13.

    Article  PubMed  Google Scholar 

  27. Catalona WJ, Kadmon D, Crane DB. Effect of mini-dose heparin on lymphocele formation following extraperitoneal pelvic lymphadenectomy. J Urol. 1980;123(6):890–2.

    PubMed  CAS  Google Scholar 

  28. Lee JY, Diaz RR, Cho KS, Yu HS, Chung JS, Ham WS, et al. Lymphocele after extraperitoneal robot-assisted radical prostatectomy: A propensity score-matching study. Int J Urol. 2013.

  29. Kropfl D, Krause R, Hartung R, Pfeiffer R, Behrendt H. Subcutaneous heparin injection in the upper arm as a method of avoiding lymphoceles after lymphadenectomies in the lower part of the body. Urol Int. 1987;42(6):416–23.

    Article  PubMed  CAS  Google Scholar 

  30. • Orvieto MA, Coelho RF, Chauhan S, Palmer KJ, Rocco B, Patel VR. Incidence of lymphoceles after robot-assisted pelvic lymph node dissection. BJU Int. 2011;108(7):1185–90. This study demonstrated that lymphoceles are common even after transperitoneal PLND at the time of radical prostatectomy. The authors provide evidence disputing the thought that the larger space of the peritoneum leads to less lymphocele formation compared to surgery confined to the extraperitoneal space.

    Article  PubMed  Google Scholar 

  31. Stone NN, Stock RG, Unger P. Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. J Urol. 1997;158(5):1891–4.

    Article  PubMed  CAS  Google Scholar 

  32. Lallas CD, Pe ML, Thumar AB, Chandrasekar T, Lee FC, McCue P, et al. Comparison of lymph node yield in robot-assisted laparoscopic prostatectomy with that in open radical retropubic prostatectomy. BJU Int. 2011;107(7):1136–40.

    Article  PubMed  Google Scholar 

  33. Loeb S, Partin AW, Schaeffer EM. Complications of pelvic lymphadenectomy: do the risks outweigh the benefits? Rev Urol. 2010;12(1):20–4.

    PubMed  Google Scholar 

  34. Williams SK, Rabbani F. Complications of lymphadenectomy in urologic surgery. Urol Clin North Am. 2011;38(4):507–18. vii.

    Article  PubMed  Google Scholar 

  35. Burnett AL, Brendler CB. Femoral neuropathy following major pelvic surgery: etiology and prevention. J Urol. 1994;151(1):163–5.

    PubMed  CAS  Google Scholar 

  36. Scarpa RM, Carrieri G, Gussoni G, Tubaro A, Conti G, Pagliarulo V, et al. Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study. Eur Urol. 2007;51(1):130–5. discussion 136.

    Article  PubMed  Google Scholar 

  37. Rice KR, Brassell SA, McLeod DG. Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol. 2010;12(2–3):e111–24.

    PubMed  Google Scholar 

  38. Van Hemelrijck M, Garmo H, Holmberg L, Bill-Axelson A, Carlsson S, Akre O, et al. Thromboembolic events following surgery for prostate cancer. Eur Urol. 2013;63(2):354–63.

    Article  PubMed  Google Scholar 

  39. Clement C, Rossi P, Aissi K, Barthelemy P, Guibert N, Auquier P, et al. Incidence, risk profile and morphological pattern of lower extremity venous thromboembolism after urological cancer surgery. J Urol. 2011;186(6):2293–7.

    Article  PubMed  Google Scholar 

  40. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):381S–453S.

    Article  PubMed  CAS  Google Scholar 

  41. • Eifler JB, Levinson AW, Hyndman ME, Trock BJ, Pavlovich CP. Pelvic lymph node dissection is associated with symptomatic venous thromboembolism risk during laparoscopic radical prostatectomy. J Urol. 2011;185(5):1661–5. This study demonstrated that PLND doubles the risk of venous thromboembolism during laparoscopic radical prostatectomy.

    Article  PubMed  CAS  Google Scholar 

  42. Forrest JB, Clemens JQ, Finamore P, Leveillee R, Lippert M, Pisters L, et al. AUA Best Practice Statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery. J Urol. 2009;181(3):1170–7.

    Article  PubMed  Google Scholar 

  43. Feng T, Patel HD, Allaf ME. Pudendal artery pseudoaneurysm after robot-assisted laparoscopic radical prostatectomy. Urology. 2013;81(1):e5–6.

    Article  PubMed  Google Scholar 

  44. Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol. 1982;128(2):315–20.

    PubMed  CAS  Google Scholar 

  45. Donohue JP. Nerve-sparing retroperitoneal lymphadenectomy for testis cancer. Evolution of surgical templates for low-stage disease. Eur Urol. 1993;23 Suppl 2:44–6.

    PubMed  Google Scholar 

  46. Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP. Complications of primary retroperitoneal lymph node dissection. J Urol. 1994;152(2 Pt 1):424–7.

    PubMed  CAS  Google Scholar 

  47. Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP. Complications of post-chemotherapy retroperitoneal lymph node dissection. J Urol. 1995;153(3 Pt 2):976–80.

    PubMed  CAS  Google Scholar 

  48. Evans JG, Spiess PE, Kamat AM, Wood CG, Hernandez M, Pettaway CA, et al. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience. J Urol. 2006;176(4 Pt 1):1463–7.

    Article  PubMed  Google Scholar 

  49. Mullins JK, Pierorazio PM, Hyams ES, Mitchell SE, Allaf ME. Lymphangiography with sclerotherapy: a novel therapy for refractory chylous ascites. Can J Urol. 2012;19(3):6250–4.

    PubMed  Google Scholar 

  50. Jewett MA, Kong YS, Goldberg SD, Sturgeon JF, Thomas GM, Alison RE, et al. Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol. 1988;139(6):1220–4.

    PubMed  CAS  Google Scholar 

  51. Donohue JP, Foster RS, Rowland RG, Bihrle R, Jones J, Geier G. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol. 1990;144(2 Pt 1):287–91. discussion 291–2.

    PubMed  CAS  Google Scholar 

  52. Abouassaly R, Klein EA, Raghavan D. Complications of surgery and chemotherapy for testicular cancer. Urol Oncol. 2005;23(6):447–55.

    Article  PubMed  Google Scholar 

  53. Bhayani SB, Ong A, Oh WK, Kantoff PW, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update. Urology. 2003;62(2):324–7.

    Article  PubMed  Google Scholar 

  54. Guzzo TJ, Gonzalgo ML, Allaf ME. Laparoscopic retroperitoneal lymph node dissection with therapeutic intent in men with clinical stage I nonseminomatous germ cell tumors. J Endourol. 2010;24(11):1759–63.

    Article  PubMed  Google Scholar 

  55. Hyams ES, Pierorazio P, Proteek O, Sroka M, Kavoussi LR, Allaf ME. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience. J Urol. 2012;187(2):487–92.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Dr. Mark W. Ball reported no potential conflicts of interest relevant to this article.

Dr. Michael A. Gorin reported no potential conflicts of interest relevant to this article.

Dr. Mohamad E. Allaf reported no potential conflicts of interest relevant to this article.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, 1800 Orleans St, Baltimore, MD, 21287, USA

    Mark W. Ball, Michael A. Gorin & Mohamad E. Allaf

Authors
  1. Mark W. Ball
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael A. Gorin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohamad E. Allaf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark W. Ball.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ball, M.W., Gorin, M.A. & Allaf, M.E. Reducing Morbidity of Pelvic and Retroperitoneal Lymphadenectomy. Curr Urol Rep 14, 488–495 (2013). https://doi.org/10.1007/s11934-013-0350-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-013-0350-9

Keywords

Search

Navigation